Immunovant, Inc.IMVTNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-487.17M
↓ 135% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-207.15M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-487.17M | -11.2% |
| 2025 | $-438.15M | -62.2% |
| 2024 | $-270.21M | -29.7% |
| 2023 | $-208.28M | -33.5% |
| 2022 | $-156.03M | -44.3% |
| 2021 | $-108.12M | -81.2% |
| 2020 | $-59.68M | -13261677.8% |
| 2019 | $-450.00 | +100.0% |
| 2018 | $-136.74M | - |